Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Scarborough

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 20, 2004
Protease-activated receptor-2 antagonists and agonistsRobert M Scarborough
Journal of Medicinal Chemistry|May 16, 2003
Metal coordination-based inhibitors of adenylyl cyclase: novel potent P-site antagonistsDaniel E Levy, Ming Bao, Diana B Cherbavaz, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitorsTing Su, Hua Yang, Deborah Volkots, et al.
The Journal of Biological Chemistry|July 21, 2004
Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deteriorationKousaku Iwatsubo, Susumu Minamisawa, Takashi Tsunematsu, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Identification of 4-piperazin-1-yl-quinazoline template based aryl and benzyl thioureas as potent, selective, and orally bioavailable inhibitors of platelet-derived growth factor (PDGF) receptorJulie A Heath, Mukund M Mehrotra, Shannon Chi, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2009
Anthranilamide-based N,N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SARPenglie Zhang, Liang Bao, Jingmei Fan, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2002
Design and synthesis of factor Xa inhibitors and their prodrugsYonghong Song, Lane Clizbe, Chhaya Bhakta, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
Substituted acrylamides as factor Xa inhibitors: improving bioavailability by P1 modificationYonghong Song, Lane Clizbe, Chhaya Bhakta, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Inhibitory effect of carboxylic acid group on hERG bindingBing-Yan Zhu, Zhaozhong J Jia, Penglie Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Design, synthesis, and structure-activity relationships of unsubstituted piperazinone-based transition state factor Xa inhibitorsWenrong Huang, Mary Ann Naughton, Hua Yang, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 20, 2004
Protease-activated receptor-2 antagonists and agonistsRobert M Scarborough
Journal of Medicinal Chemistry|May 16, 2003
Metal coordination-based inhibitors of adenylyl cyclase: novel potent P-site antagonistsDaniel E Levy, Ming Bao, Diana B Cherbavaz, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitorsTing Su, Hua Yang, Deborah Volkots, et al.
The Journal of Biological Chemistry|July 21, 2004
Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deteriorationKousaku Iwatsubo, Susumu Minamisawa, Takashi Tsunematsu, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Identification of 4-piperazin-1-yl-quinazoline template based aryl and benzyl thioureas as potent, selective, and orally bioavailable inhibitors of platelet-derived growth factor (PDGF) receptorJulie A Heath, Mukund M Mehrotra, Shannon Chi, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2009
Anthranilamide-based N,N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SARPenglie Zhang, Liang Bao, Jingmei Fan, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2002
Design and synthesis of factor Xa inhibitors and their prodrugsYonghong Song, Lane Clizbe, Chhaya Bhakta, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
Substituted acrylamides as factor Xa inhibitors: improving bioavailability by P1 modificationYonghong Song, Lane Clizbe, Chhaya Bhakta, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Inhibitory effect of carboxylic acid group on hERG bindingBing-Yan Zhu, Zhaozhong J Jia, Penglie Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Design, synthesis, and structure-activity relationships of unsubstituted piperazinone-based transition state factor Xa inhibitorsWenrong Huang, Mary Ann Naughton, Hua Yang, et al.
Pageof 3